Grant of Options and RSUs and PDMR Dealings
April 04, 2019 02:00 ET
|
Verona Pharma plc
LONDON, April 04, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing...
Verona Pharma to Present at H.C. Wainwright Global Life Sciences Conference
March 26, 2019 03:00 ET
|
Verona Pharma plc
LONDON, March 26, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (NASDAQ: VRNA) (“Verona Pharma”), a clinical stage biopharmaceutical company focused on developing and commercializing...
PDMR Dealing
March 25, 2019 03:00 ET
|
Verona Pharma plc
LONDON, March 25, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing...
2018 Annual Report and Accounts and Notice of AGM
March 22, 2019 12:00 ET
|
Verona Pharma plc
LONDON, March 22, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma”), a clinical stage biopharmaceutical company focused on developing and commercializing...
Dr. Martin Edwards Joins Verona Pharma as Non-Executive Director
March 21, 2019 03:00 ET
|
Verona Pharma plc
LONDON, March 21, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical stage biopharmaceutical company focused on developing and commercializing...
PDMR Dealing
March 20, 2019 03:00 ET
|
Verona Pharma plc
LONDON, March 20, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing...
PDMR Dealing
March 11, 2019 05:48 ET
|
Verona Pharma plc
LONDON, March 11, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing...
PDMR Dealing
March 07, 2019 03:14 ET
|
Verona Pharma plc
LONDON, March 07, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing...
PDMR Dealing
March 05, 2019 04:48 ET
|
Verona Pharma plc
LONDON, March 05, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing...
Verona Pharma Reports Positive Interim Data with Ensifentrine Dry Powder Inhaler Formulation in First of Two-Part Phase 2 Clinical Trial in COPD
March 04, 2019 02:00 ET
|
Verona Pharma plc
Single dose of ensifentrine DPI formulation produced statistically significant and clinically meaningful dose-dependent bronchodilator response and was well tolerated at all doses Data support...